JPMorgan Chase & Co’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.5M | Buy |
255,837
+247,171
| +2,852% | +$21.7M | ﹤0.01% | 1665 |
|
|
2025
Q1 | $790K | Sell |
8,666
-2,650
| -23% | -$242K | ﹤0.01% | 3778 |
|
|
2024
Q4 | $976K | Buy |
11,316
+1,774
| +19% | +$153K | ﹤0.01% | 3809 |
|
|
2024
Q3 | $907K | Sell |
9,542
-146,021
| -94% | -$13.9M | ﹤0.01% | 3695 |
|
|
2024
Q2 | $14.2M | Buy |
155,563
+49,051
| +46% | +$4.49M | ﹤0.01% | 1872 |
|
|
2024
Q1 | $9.66M | Sell |
106,512
-51,626
| -33% | -$4.68M | ﹤0.01% | 2144 |
|
|
2023
Q4 | $12.9M | Sell |
158,138
-45,051
| -22% | -$3.67M | ﹤0.01% | 1926 |
|
|
2023
Q3 | $16.2M | Buy |
203,189
+150,365
| +285% | +$12M | ﹤0.01% | 1650 |
|
|
2023
Q2 | $4.16M | Buy |
52,824
+1,739
| +3% | +$137K | ﹤0.01% | 2618 |
|
|
2023
Q1 | $3.97M | Buy |
51,085
+50,497
| +8,588% | +$3.92M | ﹤0.01% | 2593 |
|
|
2022
Q4 | $46K | Buy |
+588
| New | +$46K | ﹤0.01% | 4765 |
|
|
2019
Q4 | – | Sell |
-100,880
| Closed | -$5.74M | – | 4836 |
|
|
2019
Q3 | $5.74M | Buy |
100,880
+100,000
| +11,364% | +$5.69M | ﹤0.01% | 2128 |
|
|
2019
Q2 | $51K | Hold |
880
| – | – | ﹤0.01% | 4242 |
|
|
2019
Q1 | $53K | Sell |
880
-907
| -51% | -$54.6K | ﹤0.01% | 4212 |
|
|
2018
Q4 | $98K | Sell |
1,787
-82
| -4% | -$4.5K | ﹤0.01% | 4054 |
|
|
2018
Q3 | $120K | Sell |
1,869
-80
| -4% | -$5.14K | ﹤0.01% | 4050 |
|
|
2018
Q2 | $115K | Hold |
1,949
| – | – | ﹤0.01% | 4036 |
|
|
2018
Q1 | $111K | Hold |
1,949
| – | – | ﹤0.01% | 3902 |
|
|
2017
Q4 | $116K | Sell |
1,949
-200
| -9% | -$11.9K | ﹤0.01% | 3860 |
|
|
2017
Q3 | $123K | Sell |
2,149
-150
| -7% | -$8.59K | ﹤0.01% | 3588 |
|
|
2017
Q2 | $136K | Buy |
2,299
+50
| +2% | +$2.96K | ﹤0.01% | 3486 |
|
|
2017
Q1 | $124K | Sell |
2,249
-250,057
| -99% | -$13.8M | ﹤0.01% | 3644 |
|
|
2016
Q4 | $13.2M | Buy |
252,306
+250,000
| +10,841% | +$13.1M | ﹤0.01% | 1530 |
|
|
2016
Q3 | $133K | Sell |
2,306
-688
| -23% | -$39.7K | ﹤0.01% | 3364 |
|
|
2016
Q2 | $175K | Sell |
2,994
-90
| -3% | -$5.26K | ﹤0.01% | 3267 |
|
|
2016
Q1 | $177K | Sell |
3,084
-75
| -2% | -$4.3K | ﹤0.01% | 3176 |
|
|
2015
Q4 | $206K | Sell |
3,159
-1,234
| -28% | -$80.5K | ﹤0.01% | 3126 |
|
|
2015
Q3 | $277K | Buy |
4,393
+45
| +1% | +$2.84K | ﹤0.01% | 3093 |
|
|
2015
Q2 | $308K | Buy |
4,348
+622
| +17% | +$44.1K | ﹤0.01% | 3206 |
|
|
2015
Q1 | $262K | Buy |
+3,726
| New | +$262K | ﹤0.01% | 3265 |
|
|
2014
Q1 | – | Sell |
-106,981
| Closed | -$5.68M | – | 3574 |
|
|
2013
Q4 | $5.68M | Buy |
106,981
+15,328
| +17% | +$814K | ﹤0.01% | 1945 |
|
|
2013
Q3 | $4.39M | Buy |
91,653
+10,676
| +13% | +$511K | ﹤0.01% | 2111 |
|
|
2013
Q2 | $3.68M | Buy |
+80,977
| New | +$3.68M | ﹤0.01% | 2152 |
|